• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention 
    •   QMRO Home
    • William Harvey Research Institute
    • Centre for Clinical Pharmacology
    • Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention
    •   QMRO Home
    • William Harvey Research Institute
    • Centre for Clinical Pharmacology
    • Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention

    View/Open
    Accepted version (124.8Kb)
    DOI
    10.1136/annrheumdis-2016-309748
    Journal
    Heart
    ISSN
    1355-6037
    Metadata
    Show full item record
    Abstract
    © 2016 BMJ Publishing Group Ltd & British Cardiovascular Society. Objective Recent work suggests that intracoronary nitrite reduces myocardial infarct size following primary percutaneous coronary intervention (PPCI) for acute myocardial infarction (AMI), although the exact mechanisms are unclear. We explored the effects of nitrite on reperfusion-induced inflammation, by assessing the levels of specific pro-inflammatory mediators, chemokines and adhesion molecules in plasma and circulating cell subtypes as exploratory end points in the NITRITE-AMI cohort. Methods Peripheral blood leucocyte subsets, cell adhesion molecules, high-sensitivity C reactive protein (hs-CRP), the monocyte and neutrophil chemoattractants CCL2 and CXCL1, CXCL5, respectively were measured in the blood of patients who received either intracoronary sodium nitrite (N=40) or placebo (N=40) during PPCI for AMI. Major adverse cardiac events were recorded at 3 years post-PPCI. Results In the placebo-treated patients, total circulating neutrophil numbers and levels of hs-CRP were raised postreperfusion and then decreased over time; in nitritetreated patients these changes were suppressed compared with placebo up to 6 months post-PPCI (p < 0.01). This effect was associated with reduced expression of neutrophil CD11b, plasma CXCL1, CXCL5 and CCL2 levels (p < 0.05). There were no differences in the number of other any other leucocyte population measured (monocytes and lymphocytes) or activation markers expressed by these cells between the treatment groups. These effects were associated with a reduction in both microvascular obstruction and infarct size. Conclusions Important reductions in neutrophil numbers and activation post-PPCI in patients with ST elevated myocardial infarction were associated with nitrite treatment, an effect we propose likely underlies, at least in part, the beneficial effects of nitrite upon infarct size.
    Authors
    Jones, DA; Khambata, RS; Andiapen, M; Rathod, KS; Mathur, A; Ahluwalia, A
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/17869
    Collections
    • Centre for Clinical Pharmacology [830]
    Copyright statements
    © 2016, BMJ Publishing Group Ltd and the British Cardiovascular Society
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.